Antimicrobial stewardship interventions for Staphylococcus aureus bacteremia: cost analysis of alternative therapies

Authors

Charles Hoffmann, University of Rochester Medical Center
Christopher Evans, University of Rochester Medical Center
David Hutchinson, St. John Fisher UniversityFollow
Jack Brown, St. John Fisher University

Document Type

Poster Presentation

Publication Date

10-28-2016

Abstract

Staphylococcus aureus bacteremia (SAB) is a significant cost burden to the US Health System. Clinical management of SAB becomes challenging in patients who are not candidates for or fail first line therapies such as vancomycin (V), semisynthetic penicillin’s (SSP) or cefazolin (C). Alternative agents for SAB includes ceftaroline (CPT) and daptomycin (DAP), however outcomes data are limited. The purpose of this study was to assess inpatient pharmacy drug costs of alternative antimicrobials for treatment of SAB in patients who cannot tolerate or fail recommended therapies from the hospital perspective.

Comments

Poster presented at IDWeek in New Orleans, Louisiana, on October 28, 2016.

Publication Information

Hoffmann, Charles; Evans, Christopher; Hutchinson, David; and Brown, Jack, "Antimicrobial stewardship interventions for Staphylococcus aureus bacteremia: cost analysis of alternative therapies" (2016). Pharmacy Faculty/Staff Publications. Paper 418.
https://fisherpub.sjf.edu/pharmacy_facpub/418

Please note that the Publication Information provides general citation information and may not be appropriate for your discipline. To receive help in creating a citation based on your discipline, please visit http://libguides.sjfc.edu/citations.